Table_5_Fucose as a potential therapeutic molecule against the immune-mediated inflammation in IgA nepharopathy: An unrevealed link.xlsx by Jianbo Qing (12864269)

Trauma-distant activation of inflammatory response regulators in the non-injured left lung. by Marc-Alexander Oestreich (13961375)

CYP3A activity in HepaRG^® cells treated with each test compound. by Masao Togao (21696599)

Receiver-operating characteristic curves of % PCT decrease for predicting survival (A) and recovery from dialysis (B) within 28 days after CRRT initiation in patients with SIAKI re... by Il Young Kim (10757390)

CYP3A activity in DPX-2 cells treated with each test compound. by Masao Togao (21696599)

CYP3A activity in primary human hepatocytes treated with indoxyl sulfate (IS). by Masao Togao (21696599)

CYP gene expression of indoxyl sulfate (IS) in primary human hepatocytes. by Masao Togao (21696599)

Percentage of the predicted <i>CYP2C19</i> (A), <i>CYP3A5</i> (B), <i>DPYD</i> (C), <i>CYP2C9</i> (D), <i>TPMT</i> (E), <i>NUDT15</i> (F) metabolizer groups. by Ewa Goljan (3463487)

Subjects:

120-kDa Notch1 transmembrane domain (N1™) is decreased in Pn−/− molar PDL. by Hideyuki Tanabe (243557)

Table_1_A T3SS Regulator Mutant HY9901 ΔaraC of Vibrio alginolyticus Decreased the Expression of HopPmaJ and Provided Protection to Danio rerio as a Live-Attenuated Vaccine.xls by Junlin Wang (4029803)

“…The swimming ability of ΔaraC decreased and exhibited a 2,600 times reduction in virulence to zebrafish. …”

Image_2_Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.tif by Liina Tserel (420665)

“…We here studied the antibody and T cell responses, and a wide range of inflammation markers, in 56 SARS-CoV-2 antibody-positive individuals, identified by a population screen after the first wave of SARS-CoV-2 infection. …”

Image_3_Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.tif by Liina Tserel (420665)

“…We here studied the antibody and T cell responses, and a wide range of inflammation markers, in 56 SARS-CoV-2 antibody-positive individuals, identified by a population screen after the first wave of SARS-CoV-2 infection. …”

Image_1_Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.tif by Liina Tserel (420665)

“…We here studied the antibody and T cell responses, and a wide range of inflammation markers, in 56 SARS-CoV-2 antibody-positive individuals, identified by a population screen after the first wave of SARS-CoV-2 infection. …”

<i>sv75</i> and <i>sv76</i> cause decreased fat accumulation in the intestine. by Ming Sheng (718354)

Morphine decreases neuronal excitability in enteric AHP +ve neurons without changing the resting membrane potential. by Tricia H. Smith (306217)

“…Statistical analysis (D) indicates that morphine (3 µM) causes a significant increase in threshold and a decrease in action potential height (taken at 30% height at 0.09 nA current injection) while leaving the resting membrane potential unaffected (* = p<0.05 via t-test). n = 6 for all analyses. …”

UV-B impairs PIF4 binding to shade marker genes’ promoters in a UVR8-dependent manner. by Eleni Tavridou (8822789)

Immune challenge increases the intensity of some Ni-Sp185/333 proteins and decreases the intensity of others. by Lauren S. Sherman (800584)

“…(B) After challenge with <i>V</i>. <i>diazotrophicus</i>, larger MW proteins decrease in intensity (compare white arrows in A and B), whereas the monomers increase in intensity (compare black arrows in A and B).…”

Decreased expression of Notch factors in HUVEC-HBVP cocultures after 16K hPRL treatment. by Ngoc-Quynh-Nhu Nguyen (340032)

PA J10 mutant does not affect the formation of VLPs but decreases viral RNA packaging efficiency. by Yuhong Liang (335908)

GRIP1^-/- platelets do not have decreased velocity in ionophore-stimulated blood vessels. by Kristina L. Modjeski (3123072)

“…<p>A) GRIP1^-/- platelets do not have a decreased velocity in an ionophore-stimulated pinna vessel. …”